Published in Arthritis Rheum on July 01, 1983
An HLA-DR1 transgene confers susceptibility to collagen-induced arthritis elicited with human type II collagen. J Exp Med (1997) 1.89
Use of soluble peptide-DR4 tetramers to detect synovial T cells specific for cartilage antigens in patients with rheumatoid arthritis. Proc Natl Acad Sci U S A (2000) 1.46
Epitope spreading to citrullinated antigens in mouse models of autoimmune arthritis and demyelination. Arthritis Res Ther (2008) 1.40
Incidence of antibodies to native and denatured cartilage collagens (types II, IX, and XI) and to type I collagen in rheumatoid arthritis. Ann Rheum Dis (1987) 1.19
Mechanisms of disruption of the articular cartilage surface in inflammation. Neutrophil elastase increases availability of collagen type II epitopes for binding with antibody on the surface of articular cartilage. J Clin Invest (1991) 1.10
Induction of IL-10-producing CD4+CD25+ T cells in animal model of collagen-induced arthritis by oral administration of type II collagen. Arthritis Res Ther (2004) 1.02
Patterns of autoreactivity to collagen type II in autoimmune MRL/l mice. Clin Exp Immunol (1986) 1.02
HLA-DQB1 polymorphism determines incidence, onset, and severity of collagen-induced arthritis in transgenic mice. Implications in human rheumatoid arthritis. J Clin Invest (1997) 1.01
What do anti-collagen antibodies mean? Ann Rheum Dis (1990) 0.99
Bacterial lipopolysaccharide acts as an adjuvant to induce autoimmune arthritis in mice. Immunology (2000) 0.97
Serum samples of patients with rheumatoid arthritis contain a specific autoantibody to "denatured" aldolase A in the osteoblast-like cell line, MG-63. Ann Rheum Dis (1999) 0.86
Are there autoantibodies reacting against citrullinated peptides derived from type I and type II collagens in patients with rheumatoid arthritis? Ann Rheum Dis (2005) 0.86
Human anti-fibronectin antibodies in systemic lupus erythematosus: occurrence and antigenic specificity. Clin Exp Immunol (1994) 0.84
Epitope specificity of antibody response against human type II collagen in the mouse susceptible to collagen-induced arthritis and patients with rheumatoid arthritis. Clin Exp Immunol (1988) 0.83
VH usage and somatic hypermutation in peripheral blood B cells of patients with rheumatoid arthritis (RA). Clin Exp Immunol (1998) 0.82
The immune response of guinea-pigs to type II collagen: poor cross-reactivity with homologous type II collagen accounts for resistance to collagen-induced arthritis. Immunology (1988) 0.81
The role of lipopolysaccharide injected systemically in the reactivation of collagen-induced arthritis in mice. Br J Pharmacol (2000) 0.81
Fine specificity of serum anticollagen molecules in experimental immune synovitis. Ann Rheum Dis (1985) 0.79
Humoral immunity to link protein in patients with inflammatory joint disease, osteoarthritis, and in non-arthritic controls. Ann Rheum Dis (1988) 0.77
Pattern of humoral reactivity to type II collagen in rheumatoid arthritis. Clin Exp Immunol (1989) 0.77
Identification of antibody epitopes in the CB-11 peptide of bovine type II collagen recognized by sera from arthritis-susceptible and -resistant rhesus monkeys. Clin Exp Immunol (1994) 0.76
Pepsinogen--an immunoglobulin binding artefact in 'collagen' preparations. Clin Exp Immunol (1986) 0.75
Autoantibodies to types I and IV collagen and heart valve disease in systemic lupus erythematosus/antiphospholipid syndrome. Clin Rheumatol (2017) 0.75
Autoimmunity to type II collagen an experimental model of arthritis. J Exp Med (1977) 10.09
A gene expression map for Caenorhabditis elegans. Science (2001) 9.74
An outbreak of meningococcal disease in Gloucestershire. Lancet (1986) 6.38
Integrating genotype and phenotype information: an overview of the PharmGKB project. Pharmacogenetics Research Network and Knowledge Base. Pharmacogenomics J (2001) 5.94
Principal components analysis to summarize microarray experiments: application to sporulation time series. Pac Symp Biocomput (2000) 5.83
Type II collagen-induced arthritis in mice. I. Major histocompatibility complex (I region) linkage and antibody correlates. J Exp Med (1981) 5.76
The Stonehouse survey: nasopharyngeal carriage of meningococci and Neisseria lactamica. Epidemiol Infect (1987) 4.40
Stimulation of the chemotactic migration of human fibroblasts by transforming growth factor beta. J Exp Med (1987) 4.35
Serum transfer of collagen-induced arthritis in mice. J Exp Med (1983) 3.74
Purification and properties of M protein extracted from group A streptococci with pepsin: covalent structure of the amino terminal region of type 24 M antigen. J Exp Med (1977) 3.62
Primary structure of protective antigens of type 24 streptococcal M protein. J Biol Chem (1980) 3.39
Type-specific protective immunity evoked by synthetic peptide of Streptococcus pyogenes M protein. Nature (1981) 3.38
Collagen-and collagen peptide-induced chemotaxis of human blood monocytes. J Exp Med (1976) 3.17
Biochemical and immunological characterization of the secreted forms of human neutrophil gelatinase. J Biol Chem (1985) 3.15
Type II collagen-induced arthritis in rats. Passive transfer with serum and evidence that IgG anticollagen antibodies can cause arthritis. J Exp Med (1982) 3.06
The chemotactic attraction of human fibroblasts to a lymphocyte-derived factor. J Exp Med (1976) 3.04
Chemotactic attraction of human fibroblasts to type I, II, and III collagens and collagen-derived peptides. Proc Natl Acad Sci U S A (1978) 3.00
Repeating covalent structure of streptococcal M protein. Proc Natl Acad Sci U S A (1978) 2.89
Humoral and cellular sensitivity to collagen in type II collagen-induced arthritis in rats. J Clin Invest (1978) 2.84
Gram-negative sepsis: detection of endotoxemia with the limulus test. With studies of associated changes in blood coagulation, serum lipids, and complement. Ann Intern Med (1972) 2.79
Transforming growth factor-beta increases steady state levels of type I procollagen and fibronectin messenger RNAs posttranscriptionally in cultured human dermal fibroblasts. J Clin Invest (1987) 2.74
Diabetic clinic in a general practice. Br Med J (1971) 2.71
Induction of arthritis with monoclonal antibodies to collagen. J Immunol (1992) 2.64
Collagen polymorphism in idiopathic chronic pulmonary fibrosis. J Clin Invest (1976) 2.60
Nature and specificity of the immune response to collagen in type II collagen-induced arthritis in mice. J Clin Invest (1982) 2.29
The role of C5 and T-cell receptor Vb genes in susceptibility to collagen-induced arthritis. Immunogenetics (1991) 2.29
Interleukin 1 stimulation of collagenase production by cultured fibroblasts. J Exp Med (1983) 2.28
Studies on the location of intermolecular cross-links in collagen. Isolation of a CNBr peptide containing -hydroxylysinonorleucine. Biochemistry (1972) 2.25
Collagen-induced arthritis, an animal model of autoimmunity. Life Sci (1997) 2.20
Lymphocyte modulation of fibroblast function in vitro: stimulation and inhibition of collagen production by different effector molecules. J Immunol (1984) 2.18
Collagen-induced arthritis in rats. Evaluation of early immunologic events. Arthritis Rheum (1979) 2.16
Isolation of two distinct collagens from chick cartilage. Biochemistry (1970) 2.14
Degradation of type IV (basement membrane) collagen by a proteinase isolated from human polymorphonuclear leukocyte granules. J Biol Chem (1980) 2.13
Collagen autoimmune arthritis. Annu Rev Immunol (1984) 2.10
Induction of fibroblast chemotaxis by fibronectin. Localization of the chemotactic region to a 140,000-molecular weight non-gelatin-binding fragment. J Exp Med (1981) 2.10
Influenza A and meningococcal disease. Lancet (1991) 2.00
Regulation of mRNAs for type-1 plasminogen activator inhibitor, fibronectin, and type I procollagen by transforming growth factor-beta. Divergent responses in lung fibroblasts and carcinoma cells. J Biol Chem (1988) 1.93
An HLA-DR1 transgene confers susceptibility to collagen-induced arthritis elicited with human type II collagen. J Exp Med (1997) 1.89
Outbreaks of waterborne infectious intestinal disease in England and Wales, 1992-5. Epidemiol Infect (1998) 1.74
Primary structural similarities between types 5 and 24 M proteins of Streptococcus pyogenes. Biochem Biophys Res Commun (1980) 1.72
Collagen-induced arthritis in rats. Comparison of vitreous and cartilage-derived collagens. Arthritis Rheum (1979) 1.71
Collagen polymorphism in normal and cirrhotic human liver. J Clin Invest (1977) 1.68
Interaction of lipoteichoic acid of group A streptococci with human platelets. Infect Immun (1977) 1.65
Characterization of the alpha-chains of chick skin collagen and the nature of the NH2-terminal cross-link region. Biochemistry (1969) 1.63
Characterization of the cyanogen bromide peptides from the alpha 1 chain of chick skin collagen. Biochemistry (1969) 1.63
Coordinate regulation of transforming growth factor beta gene expression and cell proliferation in hamster lungs undergoing bleomycin-induced pulmonary fibrosis. J Clin Invest (1989) 1.62
Community immunization programme in response to an outbreak of invasive Neisseria meningitidis serogroup C infection in the Trent region of England 1995-1996. J Public Health Med (1997) 1.62
Isolation and purification of collagen alpha 1(I) receptor from human platelet membrane. J Biol Chem (1982) 1.62
Smoking, the environment and meningococcal disease: a case control study. Epidemiol Infect (1994) 1.62
The nature and location of intramolecular cross-links in collagen. Proc Natl Acad Sci U S A (1966) 1.60
Formation of multinucleated giant cells from human monocyte precursors. Mediation by a soluble protein from antigen-and mitogen-stimulated lymphocytes. J Exp Med (1982) 1.59
Studies on the structure of collagen utilizing a collagenolytic enzyme from tadpole. Biochemistry (1966) 1.59
Evidence for cell-mediated immunity to collagen in progressive systemic sclerosis. J Lab Clin Med (1976) 1.57
Possible role of V beta T cell receptor genes in susceptibility to collagen-induced arthritis in mice. J Exp Med (1988) 1.55
Transforming growth factor beta 1 (TGF-beta 1) induced neutrophil recruitment to synovial tissues: implications for TGF-beta-driven synovial inflammation and hyperplasia. J Exp Med (1991) 1.55
The amino acid sequence of peptides from the cross-linking region of rat skin collagen. Biochemistry (1967) 1.54
Type II collagen-induced arthritis in mice. IV. Variations in immunogenetic regulation provide evidence for multiple arthritogenic epitopes on the collagen molecule. J Immunol (1985) 1.53
Collagen-induced arthritis in mice. Localization of an arthritogenic determinant to a fragment of the type II collagen molecule. J Exp Med (1985) 1.52
Type II collagen-induced arthritis in mice. II. Passive transfer and suppression by intravenous injection of anti-type II collagen antibody or free native type II collagen. Arthritis Rheum (1984) 1.52
The occurrence of cryoproteins in synovial fluid; the association of a complement-fixing activity in rheumatoid synovial fluid with cold-precipitable protein. J Clin Invest (1971) 1.51
Collagen heterogeneity. High resolution separation of native ( 1(I) 2 2 and ( 1(II) 3 and their component chains. J Biol Chem (1972) 1.50
Specific cleavage of human type III collagen by human polymorphonuclear leukocyte elastase. J Biol Chem (1980) 1.50
Collagen-induced arthritis in rats: antigen-specific suppression of arthritis and immunity by intravenously injected native type II collagen. J Immunol (1983) 1.49
Serum transfer of collagen-induced arthritis. II. Identification and localization of autoantibody to type II collagen in donor and recipient rats. Arthritis Rheum (1983) 1.48
Characterization of the cyanogen bromide peptides from the alpha-2 chain of chick skin collagen. Biochemistry (1969) 1.46
Expression of a metalloproteinase that degrades native type V collagen and denatured collagens by cultured human alveolar macrophages. J Clin Invest (1987) 1.43
Collagen-induced polyarthritis in rats: a study of native type II collagen for adjuvant activity. J Immunol (1980) 1.43
Outbreak of meningococcal disease linked to a sports club. Lancet (1998) 1.40
The role of stromelysin in the cartilage destruction that accompanies inflammatory arthritis. Arthritis Rheum (1990) 1.40
Identification of an immunosuppressive epitope of type II collagen that confers protection against collagen-induced arthritis. J Exp Med (1989) 1.39
Invasive group A streptococcal disease: should close contacts routinely receive antibiotic prophylaxis? Lancet Infect Dis (2005) 1.37
Passive transfer of arthritis to mice by injection of human anti-type II collagen antibody. Mayo Clin Proc (1984) 1.37